Drug recall · October 3, 2018
Zoledronic Acid Injection recall
Why: Failed Impurities/Degradation Specifications: OOS for unknown impurities.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL) One 100ml Single-Dose Bottle, Rx Only. NOVAPLUS Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. N+ and NOVAPLUS are registered trademarks of Vizient, Inc. NDC 43598-331-11
- Lots / codes
Batch Numbers: BS704, EXP 12/018; BS725, EXP 6/2019; BS745, EXP 11/2019.
- Quantity
- 10,530 vials
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Product was distributed to retailers, distributors, physician officers and medical facilities throughout the United States.
- Initiated
- September 12, 2018 · Voluntary: Firm initiated
- Classified
- October 26, 2018
- Reported
- October 3, 2018
- Ended
- March 3, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Zoledronic acid
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.